MedPath

Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition

Phase 3
Recruiting
Conditions
Parenteral Nutrition
Interventions
Drug: NTCB01-1
Drug: NTCB-P
Registration Number
NCT06625931
Lead Sponsor
Yuhan Corporation
Brief Summary

A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 versus NTCB-P in patients who require parenteral nutrition

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Those who are 19 years old or older at the screening visit
  • Patients are expected to require PN for more than 3 days
  • Patients who voluntarily signed the consent form
Read More
Exclusion Criteria
  • Patients are expected difficult to survive more than 3 days
  • Patients BMI is over 30 kg/m2
  • Patients having hypersensitivity to any peanut-, fish-, soy-, egg protein, or investigational drug
  • Patients with difficult peripheral intravenous line
  • Patients judged to be unsuitable for this trial by investigators
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NTCB01-1NTCB01-1-
NTCB-PNTCB-P-
Primary Outcome Measures
NameTimeMethod
Occurance rate of adverse drug reactionDay 1 to day 4
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (7)

Keimyung University Dongsan Hospital

🇰🇷

Daegu, Dalseo-gu, Korea, Republic of

Seoul Metropolitan Government Seoul National University Boramae Medical Center

🇰🇷

Seoul, Dongjak-gu, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Jongno-gu, Korea, Republic of

Kosin University Gospel Hospital

🇰🇷

Busan, Seo-gu, Korea, Republic of

The Catholic University of Korea, Seoul ST. Mary's Hospital

🇰🇷

Seoul, Seocho-Gu, Korea, Republic of

Korea University Anam Hospital

🇰🇷

Seoul, Seongbuk-gu, Korea, Republic of

Ajou University Medical Center

🇰🇷

Gyeonggi-do, Suwon-si, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath